<DOC>
	<DOCNO>NCT00152035</DOCNO>
	<brief_summary>The purpose study assess safety effectiveness SPD465 treatment ADHD . The study also look SPD465 affect sleep .</brief_summary>
	<brief_title>Safety SPD465 Treating Adults With ADHD .</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Amphetamine</mesh_term>
	<mesh_term>Dextroamphetamine</mesh_term>
	<mesh_term>Adderall</mesh_term>
	<criteria>Subject satisfy entry criterion antecedent protocol ( SPD465301 SPD465303 ) complete minimum 4 7 week doubleblind treatment without experience clinically significant adverse event . Subject must male nonpregnant female agree comply use acceptable contraceptive method . Subject terminate antecedent protocol ( SPD465301 SPD465303 ) noncompliance and/or experience serious adverse event adverse event result termination protocol . Comorbid psychiatric diagnosis significant symptom Axis II disorder severe Asix I disorder . History seizure , tic disorder , current diagnosis and/or family history Tourette 's Disorder . Females pregnant lactating .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>